Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000029

General Counsel sold 733 shares at $41.30 ($30,273)

From the SEC's structured data for this filing

Trades in this filing

Quinlan Paul T · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Sale : show line 1 in the form −733 $41.30 $30,273 31,767 D
Open-market sales · 733 sh · avg $41.30 · $30,273
Loading xslF345X05/form4.xml…